These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22153829)

  • 1. Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung.
    Taira T; Ishii G; Nagai K; Yoh K; Takahashi Y; Matsumura Y; Kojima M; Ohmatsu H; Goto K; Niho S; Takashima H; Inoue H; Ohe Y; Ochiai A
    Lung Cancer; 2012 Jun; 76(3):423-30. PubMed ID: 22153829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies.
    Ito T; Ishii G; Nagai K; Nagano T; Kojika M; Murata Y; Atsumi N; Nishiwaki Y; Miyazaki E; Kumamoto T; Ochiai A
    Lung Cancer; 2009 Mar; 63(3):418-24. PubMed ID: 18657337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness.
    Yamaguchi Y; Ishii G; Kojima M; Yoh K; Otsuka H; Otaki Y; Aokage K; Yanagi S; Nagai K; Nishiwaki Y; Ochiai A
    J Thorac Oncol; 2010 Sep; 5(9):1361-8. PubMed ID: 20631633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients.
    Takahashi Y; Ishii G; Taira T; Fujii S; Yanagi S; Hishida T; Yoshida J; Nishimura M; Nomori H; Nagai K; Ochiai A
    J Thorac Oncol; 2011 Sep; 6(9):1460-7. PubMed ID: 21849853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminin-5γ2 chain expression is associated with tumor cell invasiveness and prognosis of lung squamous cell carcinoma.
    Masuda R; Kijima H; Imamura N; Aruga N; Nakazato K; Oiwa K; Nakano T; Watanabe H; Ikoma Y; Tanaka M; Inokuchi S; Iwazaki M
    Biomed Res; 2012; 33(5):309-17. PubMed ID: 23124251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.
    Ono S; Ishii G; Nagai K; Takuwa T; Yoshida J; Nishimura M; Hishida T; Aokage K; Fujii S; Ikeda N; Ochiai A
    Chest; 2013 Apr; 143(4):963-970. PubMed ID: 23081722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
    Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
    Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-expression of podoplanin and fibroblast growth factor 1 predicts poor prognosis in patients with lung squamous cell carcinoma.
    Li J; Chen H; Li X; Wang L; Gao A; Zhang P; Lin W; Gao W; Yang D; Guo X; Liu J; Dang Q; Sun Y
    Mol Med Rep; 2017 Aug; 16(2):1643-1652. PubMed ID: 28656229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
    Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
    Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
    Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS; Kong G; Sun S; Liu D; El-Naggar AK; Khuri FR; Hong WK; Lee HY
    Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.
    Usui S; Minami Y; Shiozawa T; Iyama S; Satomi K; Sakashita S; Sato Y; Noguchi M
    Lung Cancer; 2013 Dec; 82(3):407-12. PubMed ID: 24094286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung.
    Hawthorn L; Stein L; Panzarella J; Loewen GM; Baumann H
    Lung Cancer; 2006 Aug; 53(2):129-42. PubMed ID: 16757060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
    Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
    Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer.
    Soria JC; Moon C; Kemp BL; Liu DD; Feng L; Tang X; Chang YS; Mao L; Khuri FR
    Clin Cancer Res; 2003 May; 9(5):1785-91. PubMed ID: 12738735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis].
    Qiao GB; Wu YL; Ou W; Yang XN; Zhong WZ; Lin JY; Zhao J; Xie D; Guan XY
    Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(14):913-7. PubMed ID: 16083620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of IGF1R expression in non-small-cell lung cancer.
    Nakagawa M; Uramoto H; Oka S; Chikaishi Y; Iwanami T; Shimokawa H; So T; Hanagiri T; Tanaka F
    Clin Lung Cancer; 2012 Mar; 13(2):136-42. PubMed ID: 22133293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.